ask="18.62"
ask_size="2000"
average_daily_volume="319429"
bid="17.65"
bid_size="200"
book_value="3.21"
change="-0.15"
change_from_200_day_moving_average="5.03"
change_from_50_day_moving_average="0.58"
change_from_52_week_high="-5.19"
change_From_52_week_low="13.24"
change_in_percent="-0.83%"
close="17.88"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.48"
ebitda="-21.87M"
eps_estimate_current_year="-2.59"
eps_estimate_next_quarter="-0.59"
eps_estimate_next_year="-2.47"
ex_dividend_date="N/A"
float_shares="7736000"
high="18.21"
high_52_weeks="23.07"
last_trade_date="2/2/2017"
last_trade_price="17.88"
last_trade_size="2804"
last_trade_time="4:00pm"
low="17.50"
low_52_weeks="4.64"
market_capitalization="177.96M"
moving_average_200_day="12.85"
moving_average_50_day="17.30"
name="Zynerba Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="30.43"
open="18.06"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+39.15%"
percent_change_from_50_day_moving_average="+3.38%"
percent_change_from_52_week_high="-22.49%"
percent_change_from_52_week_low="+285.34%"
previous_close="18.03"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="5.62"
price_per_sales="3174.80"
revenue="56524.00"
shares_outstanding="9953000"
short_ratio="7.19"
stock_exchange="NGM"
symbol="ZYNE"
volume="290170"
weeks_range_52="4.64 - 23.07"
